Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A

Cancer Immunology Immunotherapy

Volumn 46, Issue 1, 1998, Pages 7-13

  Shrayer, David P ^a   Kouttab, Nicolas ^b   Hearing, Vincent J ^c   Wanebo, Harold J ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

B700; Enterotoxin; Immunization; Melanoma

Indexed keywords

CANCER ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; DNA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; STAPHYLOCOCCUS ENTEROTOXIN A; SUPERANTIGEN; T LYMPHOCYTE ANTIGEN;

ADOLESCENT; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNIZATION; DNA DETERMINATION; GENETIC TRANSFECTION; MELANOMA; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CANCER VACCINES; ENTEROTOXINS; IMMUNIZATION; INTERLEUKIN-2; KILLER CELLS, NATURAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; SPLEEN; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES; TRANSFECTION;

EID: 0031938801     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050453     Document Type: Article

References (56)

1. Bhardway N, Young JW, Nisanian AJ, Baggers J, Steinman RM (1993) Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell. J Exp Med 178:633
2. Chapman RS, Whetton WD, Dive C (1994) The suppression of drug-induced apoptosis by activation of v-ABL protein tyrosine kinase. Cancer Res 54:5131
3. Chatila T, Scholl P, Raniesh N, Trede N, Fuleihan R, Morio T, Geha RS (1992): Cellular and molecular mechanisms of immune activation by microbial superantigens: studies using toxic shock syndrous toxin-I. Chem Immunol Basel, Karger, 55:146
4. Choi Y, Herman A, DiGiusto D, Wade T, Marrack P, Kapplcr J (1990) Residues of the variable region of the T-cell receptor β-chain that interact with S. aureus toxin superantigens. Nature 346:471
5. Ding L, Shevach EM (1996) Activated B cells express CD28/B7-independent costimulatory activity. J Immunol 157:1389
6. Dohlsten M, Sundstedt A, Bjorklund M, Hedlund G, Kalland T (1993) Superantigen-induced cytokines suppress growth of human colon-carcinoma cells. Int J Cancer 54:482
7. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539
8. Duke RC, Chervenak R, Cohen JJ (1983) Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis. Proc Natl Acad Sci USA 80:6361
9. Fidler IJ, Ananthaswamy HN, Esumi N, Radinsky R, Price JE (1991) Correlation of growth capacity of cell in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites. Anticancer Res 11:17
10. Field SJ, Tsai F-Y, Kuo F, Zubiaga AM, Kaelin WG Jr, Livingstone DM, Orkin SH, Greenberg ME (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549
11. Gillis S, Ferm MM, Ou W (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 120:2027
12. b gene on expression of melanoma-associated antigen and lectin-binding sites on B16 melanoma cells. Cancer Res 51:5212
13. Gottschalk AR, McShan CL, Merio R, Nunez, G, Quintans J (1994) Physiological cell death in B lymphocytes. 1. Differential susceptibility of WEHI-231 sublines to anti-Ig induced physiological cell death and lack of correlation with bcl-2 expression. Int Immunol 6:121
14. Grossman D, Lamphear JG, Mollick JA, Betley MJ, Rich RR (1992) Dual roles for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity. Infect Immun 60:5190
15. Hearing VJ, Gersten DM, Shrayer DP, Law LW (1994) Novel experimental approaches to melanoma diagnosis and therapy. J Dermatol 21:860
16. Hedlund G, Dohlsten M, Peterson C, Kalland T (1993) Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells. Cancer Immunol Immunother 36:89
17. Herrmann T, Maryanski JL, Romero P, Fleischer B, MacDonald HR (1990) Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. J Immunol 144:1181
18. Herrmann T, MacDonald HR (1993) The CD8 T cell response to staphylococcal enterotoxins. Immunology 5:33
19. Irwin MJ, Hudson KR, Ames KT, Fraser JD, Gascoigne NR (1993) T-cell receptor β-chain binding to enterotoxin superantigens. Immunol Rev 131:61
20. Johnson HM, Magazine H (1987) Potent mitogenic activity of Staphylococcal enterotoxin A requires induction of interleukin 2. Int Arch Allerg Appl Immunol 87:87
21. Johnson HM, Russel JK, Pontzer CH (1991) Staphylococcal enterotoxin microbial superantigens. FASEB J 5:2706
22. Kameyama K, Vieira WD, Tsukamoto K, Law LW, Hearing VJ (1990) Differentiation and tumorigenic and metastatic phenotype of murine melanoma cells. Int J Cancer 45:1151
23. Kim J, Urban RG, Strominger JL, Wiley DC (1994) Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266:1870
24. Kuroda K, Yagi J, Imanishi K, Yan X-J, Li X-Y, Fujimaki W, Kato H, Miyoshi-Akjiama T, Kumazawa Y, Abe H, Uchiyama T (1996) Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen. J Immunol 157:1422
25. Lando PA, Hedlung G, Dohlsten M, Kalland T (1991) Bacterial superantigens as antitumor agents: induction of tumor cytotoxicity in human lymphocytes by staphylococcal enterotoxin A. Cancer Immunol Immunother 33:231
26. Lando PA, Olson C, Kalland T, Newton D, Kolb M, Dohlsten M (1996) Regulation of superantigen-induced T cell activation in the absence and presence of MHC class II. J Immunol 157:2857
27. Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248:705
28. Marrack P, Blackman M, Kushnir E, Kappler J (1990) The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med 171:455
29. + T cells induced by a superantigen: roles of antigen-presenting cell. Immunology 81:513
30. Mollick JA, Cook RG, Rich RR (1989) Class II MHC molecules are specific receptors for Staphylococcal enterotoxin A. Science 244:817
31. Mollick JA, Chintagumpala M, Cook RG, Rich RR (1991) Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding activity and class II isotype. J Immunol 146:463
32. Mourad W, Al-Daccak R, Chatila T, Geha R (1993) Staphylococcal superantigens as inducers of signal transduction in MHC II class-positive cells. Immunology 5:47
33. Newell KA, Ellenhorn JDL, Bruce DS, Bluestone JA (1991) In vivo T-cell activation by Staphylococcal enterotoxin B prevents outgrowth of a malignant tumor. Proc Natl Acad Sci USA 88:1074
34. Ochi A, Migita K, Xu J, Siminovitch KJ (1993) In vivo tumor immunotherapy by a bacterial superantigen. J Immunol 151:3180
35. Peavy DL, Adler WH, Smith RT (1970) The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J Immunol 105:1453
36. Penna C, Dean PA, Nelson H (1994) Antitumor x anti-CD3 bifunctional antibodies redirect T-cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases. Cancer Res 54:2738
37. b transfection of B16 melanoma cells results in reduced tumorigenicity and metastatic competence. J Immunogenet 16:291
38. Scheglovidova ON, Ezepchuk YuV, Orlova TG (1989) Effect of staphylococcal enterotoxin A on the development of Lewis carcinoma in mice. Exp Oncol 11:73
39. Scheglovidova ON, Ezepchuk YuV, Orlova TG (1989) Effect of staphylococcal enterotoxin A-sensitized spleen cells on metastasis of mouse Lewis carcinoma. Exp Oncol 11:54
40. Shcheglovitova ON, Voskobeinik AD, Solovieva MN, Fankovskaya MK, Ezepchuk YuV, Shevlyagin VYa, Orlova TG (1987) Nonspecific antitumor activity of Staphylococcal enterotoxins. Exp Oncol 9:28
41. Shrayer D, Wanebo HJ (1995) Preimmunization of mice with formalinized cellular melanoma vaccine in combination with superantigen (staphylococcal enterotoxin A) leads to decreased growth of primary melanoma tumors and increased survival rate. In: Gardner, B (ed). 48th Annual Cancer Symposium, vol 49. Society of Surgical Oncology, Boston, p 55
42. Shrayer D, Koness J, Maizel A, Wanebo H (1992) Induction of interleukin-2, natural killer cell activity and antimelanoma antibodies resulting from immunization of mice with formalinized extracellular antigens. Melanoma Res 2:47
43. Shrayer D, Gersten DM, Koness J, Maizel A, Wanebo H, Hearing VJ (1992) B700 antigen as a component of an antimelanoma vaccine: formalinized extracellular antigens of murine melanoma (FECA). Pigment Cell Res 5:107
44. Shrayer D, Kouttab N, Maizel A, Wanebo H, Gersten DM (1993) Generation of cytotoxic antibodies to B16 murine melanoma using a formalinized vaccine (FECA): comparison to anti-B700 monoclonal antibodies. Int J Cancer 53:696
45. Shrayer DP, Koness J, Kouttab N, Bogaars H, Hearing VJ, Gersten DM, Maizel A, Wanebo H (1993) Preimmunization of mice with formalinized extracellular antigens of melanoma in combination with Il-2 and surgical resection increased survival and tumor control in metastatic melanoma model. J Surg Oncol 52:142
46. Shrayer DP, Koness J, Kouttab N, Bogaars H, Hearing VJ, Maizel A, Wanebo HJ (1994) Anti-tumor effect of polyvalent and monovalent vaccines coupled with interleukin 2 in a metastatic melanoma model. Int J Oncol 4:1121
47. Shrayer DP, Bogaars H, Hearing VJ, Wanebo HJ (1995) Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine. Cancer Immunol Immunother 40:277
48. Shrayer DP, Tremaine M, Betley MJ, Wanebo HJ (1995) Transfection of B16 F10 melanoma cells with staphylococcal enterotoxin A. In: Molecular biology of cancer. Implications for prevention and therapy. Maui, Hawaii, p C-50
49. Southern PJ, Berg P (1982) Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1:327
50. Thibodeau J, Cloutier I, Lavoie P, Labrecque N, Mourad W, Jardetzky T, Sekaly R-P (1994) Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science 266:1874
51. Uchiyama A, Hoon DSB, Morisaki T, Kaneda Y, Yuzuki DH, Morton DL (1993) Transfection of interleukin 2 gene into human melanoma cells augments cellular immune response. Cancer Res 53:949
52. Vile RG, Hart IR (1993) In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 53:962
53. Wallgren AC, Festin R, Gidlof C, Dohlsten M, Kalland T, Totterman TH (1993) Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T-cells. Blood 82:1230
54. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P (1989) The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27
55. Yagi J, Rath S, Janeway CA Jr (1991) Control of T cell responses to staphylococcal enterotoxins by stimulator cell MHC class II polymorphism. J Immunol 147:13981
56. Yan X-J, Li X-Y, Imanishi K, Kumazawa Y, Uchiyama T (1993) Study of activation of murine T cells with bacterial superantigens. J Immunol 150:3873